SG11202005548WA - Prins reaction and compounds useful in the synthesis of halichondrin macrolides and analogs thereof - Google Patents
Prins reaction and compounds useful in the synthesis of halichondrin macrolides and analogs thereofInfo
- Publication number
- SG11202005548WA SG11202005548WA SG11202005548WA SG11202005548WA SG11202005548WA SG 11202005548W A SG11202005548W A SG 11202005548WA SG 11202005548W A SG11202005548W A SG 11202005548WA SG 11202005548W A SG11202005548W A SG 11202005548WA SG 11202005548W A SG11202005548W A SG 11202005548WA
- Authority
- SG
- Singapore
- Prior art keywords
- analogs
- synthesis
- compounds useful
- prins reaction
- halichondrin macrolides
- Prior art date
Links
- 229930195695 Halichondrin Natural products 0.000 title 1
- 238000010478 Prins reaction Methods 0.000 title 1
- 230000015572 biosynthetic process Effects 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
- 239000003120 macrolide antibiotic agent Substances 0.000 title 1
- 229940041033 macrolides Drugs 0.000 title 1
- 238000003786 synthesis reaction Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/22—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains four or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D307/18—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/20—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D307/28—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Catalysts (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Furan Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201862613307P | 2018-01-03 | 2018-01-03 | |
PCT/US2019/012178 WO2019136145A1 (en) | 2018-01-03 | 2019-01-03 | Prins reaction and compounds useful in the synthesis of halichondrin macrolides and analogs thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11202005548WA true SG11202005548WA (en) | 2020-07-29 |
Family
ID=67143922
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11202005548WA SG11202005548WA (en) | 2018-01-03 | 2019-01-03 | Prins reaction and compounds useful in the synthesis of halichondrin macrolides and analogs thereof |
Country Status (9)
Country | Link |
---|---|
US (2) | US11542269B2 (en) |
EP (1) | EP3737673B1 (en) |
JP (1) | JP7469226B2 (en) |
KR (1) | KR20200105877A (en) |
CN (1) | CN111868044A (en) |
IL (1) | IL275729B2 (en) |
MX (2) | MX2020006945A (en) |
SG (1) | SG11202005548WA (en) |
WO (1) | WO2019136145A1 (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2200992B1 (en) | 2007-10-03 | 2014-02-26 | Eisai R&D Management Co., Ltd. | Intermediates and methods for the synthesis of halichondrin b analogs |
SG11201603490TA (en) * | 2013-11-04 | 2016-05-30 | Eisai R&D Man Co Ltd | Macrocyclization reactions and intermediates useful in the synthesis of analogs of halichondrin b |
CN117024469A (en) | 2015-05-07 | 2023-11-10 | 卫材R&D管理有限公司 | Macrocyclization reactions useful for the synthesis of halichondrin macrolides, intermediates and other fragments |
SG11201806133UA (en) | 2016-02-12 | 2018-08-30 | Eisai R&D Man Co Ltd | Intermediates in the synthesis of eribulin and related methods of synthesis |
SG11201811671XA (en) | 2016-06-30 | 2019-01-30 | Eisai R&D Man Co Ltd | Prins reaction and intermediates useful in the synthesis of halichondrin macrolides and analogs thereof |
IL275729B2 (en) | 2018-01-03 | 2023-09-01 | Eisai R&D Man Co Ltd | Prins reaction and compounds useful in the synthesis of halichondrin macrolides and analogs thereof |
WO2023144733A1 (en) * | 2022-01-26 | 2023-08-03 | Simon Fraser University | Compounds and processes for the preparation of eribulin |
Family Cites Families (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4107206A (en) | 1974-04-08 | 1978-08-15 | Akzona Incorporated | Benzo-bicyclononene- derivatives |
SU652180A1 (en) | 1975-12-16 | 1979-03-15 | Краснодарский политехнический институт | Method of obtaining 1-(furyl-2')-2-(2-"formyl-furyl-5") ethylene and its methyl derivative as intermediate product for synthesis of furan-2,5-dicarboxylic acid |
US5338865A (en) | 1992-03-12 | 1994-08-16 | President And Fellows Of Harvard College | Synthesis of halichondrin B and norhalichondrin B |
US5436238A (en) | 1992-03-12 | 1995-07-25 | President And Fellows Of Harvard College | Halichondrins and related compounds |
GB9206244D0 (en) | 1992-03-23 | 1992-05-06 | Pharma Mar Sa | Cytotoxic compound from a marine sponge |
TW255880B (en) | 1992-09-09 | 1995-09-01 | Hoechst Ag | |
CA2264298A1 (en) | 1996-09-06 | 1998-03-12 | Eli Lilly And Company | Catalytic selective sulfonylation process |
US6870058B2 (en) | 1996-12-03 | 2005-03-22 | The Trustees Of The University Of Pennsylvania | Compounds which mimic the chemical and biological properties of discodermolide |
US6653341B1 (en) | 1998-06-17 | 2003-11-25 | Eisai Co., Ltd. | Methods and compositions for use in treating cancer |
EP1087960B1 (en) | 1998-06-17 | 2011-03-23 | Eisai R&D Management Co., Ltd. | Macrocyclic analogs and methods of their use and preparation |
US8097648B2 (en) | 1998-06-17 | 2012-01-17 | Eisai R&D Management Co., Ltd. | Methods and compositions for use in treating cancer |
DE10106647A1 (en) | 2001-02-12 | 2002-08-22 | Univ Hannover | Ratjadon derivatives to inhibit cell growth |
EP1771431A1 (en) | 2004-06-03 | 2007-04-11 | Eisai Co., Ltd. | Intermediates for the preparation of halichondrin b |
US20060045846A1 (en) | 2004-08-30 | 2006-03-02 | Horstmann Thomas E | Reagents and methods for labeling terminal olefins |
WO2006076100A2 (en) | 2004-12-09 | 2006-07-20 | Eisai Co. Ltd. | Tubulin isotype screening in cancer therapy using halichondrin b analogs |
JP2009510005A (en) * | 2005-09-26 | 2009-03-12 | シムライズ・ゲゼルシヤフト・ミツト・ベシユレンクテル・ハフツング・ウント・コンパニー・コマンジツト・ゲゼルシヤフト | Intramolecular Prince reaction and catalyst suitable for the reaction |
WO2008010776A1 (en) | 2006-07-21 | 2008-01-24 | Agency For Science, Technology And Research | Aigialomycin d and derivatives thereof and their use in treating cancer or malaria or a microbial infection |
US8119839B2 (en) | 2007-07-20 | 2012-02-21 | Yamada Apiculture Center, Inc. | Carboxylic acid and antidepressant composition containing the same as active ingredient |
EP2200992B1 (en) | 2007-10-03 | 2014-02-26 | Eisai R&D Management Co., Ltd. | Intermediates and methods for the synthesis of halichondrin b analogs |
RU2010118063A (en) | 2007-11-16 | 2011-12-27 | ЭЙСАЙ Ар энд Ди МЕНЕДЖМЕНТ КО., ЛТД. (JP) | A NEW INTERMEDIATE COMPOUND FOR SYNTHESIS OF ANALOG OF HALICHONDRIN B AND A NEW DESULPHONILATION REACTION USED FOR OBTAINING AN INTERMEDIATE COMPOUND |
SG189739A1 (en) | 2008-04-04 | 2013-05-31 | Eisai R&D Man Co Ltd | Halichondrin b analogs |
JP5371091B2 (en) | 2009-01-23 | 2013-12-18 | 三菱レイヨン株式会社 | Method for producing monosulfonic acid ester |
SG10201500552PA (en) | 2010-01-26 | 2015-03-30 | Eisai R&D Man Co Ltd | Furo [3, 2 -b] pyrane derivatives useful in the synthesis of halichondrin b analogs |
WO2012147900A1 (en) | 2011-04-28 | 2012-11-01 | Eisai R&D Management Co., Ltd. | Microreactor process for halichondrin b analog synthesis |
EP2785687B1 (en) | 2011-11-30 | 2019-02-20 | Sandoz AG | Process for preparation of (3r)-2,4-di-leaving group-3-methylbut-1-ene |
WO2013142999A1 (en) | 2012-03-30 | 2013-10-03 | Alphora Research Inc. | Synthetic process for preparation of macrocyclic c1-keto analogs of halichondrin b and intermediates useful therein |
EP3016957A4 (en) | 2013-07-03 | 2016-11-30 | Alphora Res Inc | Synthetic process for preparation of macrocyclic c1-keto analogs of halichondrin b and intermediates useful therein including intermediates containing -so2-(p-tolyl) groups |
SG11201603490TA (en) | 2013-11-04 | 2016-05-30 | Eisai R&D Man Co Ltd | Macrocyclization reactions and intermediates useful in the synthesis of analogs of halichondrin b |
RU2676486C1 (en) | 2013-12-06 | 2018-12-29 | Эйсай Ар Энд Ди Менеджмент Ко., Лтд. | Methods for synthesis of halichondrin b analogs |
EP3191479B1 (en) | 2014-09-09 | 2020-04-08 | Cipla Limited | "process for the preparation of macrocyclic ketone analogs of halichondrin b or pharmaceutically acceptable salts and intermediates thereof" |
WO2016176560A1 (en) | 2015-04-30 | 2016-11-03 | President And Fellows Of Harvard College | Chromium-mediated coupling and application to the synthesis of halichondrins |
CN117024469A (en) * | 2015-05-07 | 2023-11-10 | 卫材R&D管理有限公司 | Macrocyclization reactions useful for the synthesis of halichondrin macrolides, intermediates and other fragments |
SG11201806133UA (en) | 2016-02-12 | 2018-08-30 | Eisai R&D Man Co Ltd | Intermediates in the synthesis of eribulin and related methods of synthesis |
SG11201811671XA (en) | 2016-06-30 | 2019-01-30 | Eisai R&D Man Co Ltd | Prins reaction and intermediates useful in the synthesis of halichondrin macrolides and analogs thereof |
US20180009825A1 (en) | 2016-07-06 | 2018-01-11 | Apicore Us Llc | Methods of making eribulin mesylate |
WO2018217894A1 (en) | 2017-05-24 | 2018-11-29 | Eisai R&D Management Co., Ltd. | Fluorine-labelled halichondrin derivatives and related methods of synthesis |
IL275729B2 (en) | 2018-01-03 | 2023-09-01 | Eisai R&D Man Co Ltd | Prins reaction and compounds useful in the synthesis of halichondrin macrolides and analogs thereof |
-
2019
- 2019-01-03 IL IL275729A patent/IL275729B2/en unknown
- 2019-01-03 MX MX2020006945A patent/MX2020006945A/en unknown
- 2019-01-03 SG SG11202005548WA patent/SG11202005548WA/en unknown
- 2019-01-03 KR KR1020207022082A patent/KR20200105877A/en not_active Application Discontinuation
- 2019-01-03 JP JP2020536884A patent/JP7469226B2/en active Active
- 2019-01-03 US US16/959,882 patent/US11542269B2/en active Active
- 2019-01-03 CN CN201980007225.0A patent/CN111868044A/en active Pending
- 2019-01-03 EP EP19735901.1A patent/EP3737673B1/en active Active
- 2019-01-03 WO PCT/US2019/012178 patent/WO2019136145A1/en unknown
-
2020
- 2020-07-13 MX MX2022009886A patent/MX2022009886A/en unknown
-
2022
- 2022-12-28 US US18/089,971 patent/US20230151022A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
IL275729B2 (en) | 2023-09-01 |
US11542269B2 (en) | 2023-01-03 |
JP7469226B2 (en) | 2024-04-16 |
MX2020006945A (en) | 2020-11-09 |
US20230151022A1 (en) | 2023-05-18 |
EP3737673A4 (en) | 2021-08-25 |
IL275729B1 (en) | 2023-05-01 |
CN111868044A (en) | 2020-10-30 |
RU2020125252A (en) | 2022-02-03 |
IL275729A (en) | 2020-08-31 |
US20200331928A1 (en) | 2020-10-22 |
KR20200105877A (en) | 2020-09-09 |
WO2019136145A1 (en) | 2019-07-11 |
MX2022009886A (en) | 2022-08-22 |
JP2021509665A (en) | 2021-04-01 |
EP3737673B1 (en) | 2024-03-06 |
EP3737673A1 (en) | 2020-11-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL275729B1 (en) | Prins reaction and compounds useful in the synthesis of halichondrin macrolides and analogs thereof | |
IL288460A (en) | Prins reaction and intermediates useful in the synthesis of halichondrin macrolides and analogs thereof | |
IL288468A (en) | Macrocyclization reactions and intermediates useful in the synthesis of analogs of halichondrin b | |
IL276376B (en) | Macrocyclization reactions and intermediates and other fragments useful in the synthesis of halichondrin macrolides | |
IL281275B (en) | Methods useful in the synthesis of halichondrin b analogs | |
IL271939A (en) | Method for the preparation of synthesis gas | |
EP3160970A4 (en) | Synthesis of halichondrin analogs and uses thereof | |
IL204791A0 (en) | Intermediates and methods for the synthesis of halichondrin b analogs | |
ZA201908217B (en) | Method for the preparation of synthesis gas | |
HK1217689A1 (en) | Synthesis of calebin-a and its biologically active analogs calebin-a | |
HRP20190286T1 (en) | Processes for the preparation of compounds, such as 3-arylbutanals, useful in the synthesis of medetomidine | |
EP3353153A4 (en) | The total synthesis of glucosepane and compounds obtained therefrom | |
HRP20181918T1 (en) | Process for the synthesis of benzazepine derivatives | |
IS2977B (en) | Process for the preparation of intermediates useful in the synthesis of eluxadoline | |
LT3713939T (en) | Improved process for the synthesis of linker-drug vc-seco | |
ME02213B (en) | Process for the synthesis of derivatives of 7,8-dimethoxy-1,3-dihydro-2h-3-benzazepin-2-one and its | |
GB201616500D0 (en) | Biological process for the conversion of xylans to xylitol |